About this trial
The primary objective is to assess in terms of frequency the adverse outcomes (premature birth, maternal-fetal haemorrhage, maternal fetal-neonatal death) of pregnancies of women attending the obstetric-gynaecological emergency department for genital bleeding beyond the 18th week of pregnancy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pregnancy beyond 18 weeks gestational age complicated by genital bleeding;
Age of the patient ≥18 years;
Delivery at the O.U. of Obstetrics and Prenatal Age Medicine
Disqualifiers
None
Trial population
The study will include pregnant patients over 18 weeks of pregnancy referred to the obstetrical emergency department of the division of Obstetrics and Prenatal Age Medicine of IRCCS Azienda Ospedaliero Universitaria di Bologna for genital blood loss.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Rate of hospitalization for genital blood loss
Percentage of preterm births
Percentage of spontaneous deliveries, operative vaginal, cesarean sections (elective, urgent, emergent)
Frequency of antihemorrhagic therapy and maternal transfusions
Secondary outcomes
Frequency of finding abnormal ultrasound findings corresponding to the etiology of bleeding
To assess whether the ultrasound capability in detecting a specific etiology of bleeding has improved over time in conjunction with the evolution of technology and resolution of ultrasound equipment.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.